Literature DB >> 32164444

AGO2 and its partners: a silencing complex, a chromatin modulator, and new features.

Xiaojing Li1, Xueying Wang1, Zeneng Cheng1, Qubo Zhu1.   

Abstract

AGO2 is the only member with catalytic activity in Argonaute family and contains four functional core domains, which are N domain, PAZ domain, MID domain, and PIWI domain from N-terminal to C-terminal. In traditional view, AGO2 serves as the catalytic engine of the RNA induced silencing complex and plays an important role in small RNAs guided post transcriptional gene silencing, including mRNA degradation and translational repression. Moreover, AGO2 also plays multiple roles in gene regulation processes in nuclei, such as chromatin remodeling, transcriptional repression and activation, double-strand break repair and alternative splicing. Recent studies have also implicated AGO2 in several other cellular processes, including alternative polyadenylation, translational activation, and transposon repression.

Entities:  

Keywords:  AGO2; cellular processes; epigenetics; gene silencing; non-coding RNA; signal transduction

Mesh:

Substances:

Year:  2020        PMID: 32164444     DOI: 10.1080/10409238.2020.1738331

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  18 in total

1.  Human exposure to low dose ionizing radiation affects miR-21 and miR-625 expression levels.

Authors:  Roghayeh Mahmoudi; Massoud Saidijam; Safoora Nikzad; Leili Tapak; Maryam Alvandi; Saeid Afshar
Journal:  Mol Biol Rep       Date:  2021-11-19       Impact factor: 2.316

2.  Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis.

Authors:  Sheng-Dean Luo; Hsin-Ting Tsai; Chung-Feng Hwang; Tai-Jan Chiu; Shau-Hsuan Li; Ya-Ling Hsu; Chang-Chun Hsiao; Chang-Han Chen
Journal:  J Exp Clin Cancer Res       Date:  2022-07-01

Review 3.  Diverse Defenses: A Perspective Comparing Dipteran Piwi-piRNA Pathways.

Authors:  Stephanie Gamez; Satyam Srivastav; Omar S Akbari; Nelson C Lau
Journal:  Cells       Date:  2020-09-27       Impact factor: 6.600

4.  YTHDF1 promotes mRNA degradation via YTHDF1-AGO2 interaction and phase separation.

Authors:  Jiong Li; Ke Chen; Xin Dong; Yating Xu; Qi Sun; Honghong Wang; Zhen Chen; Cong Liu; Rong Liu; Zhe Yang; Xiangfei Mei; Rongyu Zhang; Liuping Chang; Zongwen Tian; Jianjun Chen; Kaiwei Liang; Chunjiang He; Mengcheng Luo
Journal:  Cell Prolif       Date:  2021-11-25       Impact factor: 6.831

Review 5.  Localization and Functional Roles of Components of the Translation Apparatus in the Eukaryotic Cell Nucleus.

Authors:  Zaur M Kachaev; Sergey D Ivashchenko; Eugene N Kozlov; Lyubov A Lebedeva; Yulii V Shidlovskii
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

6.  The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.

Authors:  Yadi Zhou; Zhenghao Zhang; Mingyi Wo; Wenfang Xu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  MiR-21-5p-expressing bone marrow mesenchymal stem cells alleviate myocardial ischemia/reperfusion injury by regulating the circRNA_0031672/miR-21-5p/programmed cell death protein 4 pathway.

Authors:  Jing Zhang; Chang-Jun Luo; Xiao-Qi Xiong; Jun Li; San-Hua Tang; Lin Sun; Qiang Su
Journal:  J Geriatr Cardiol       Date:  2021-12-28       Impact factor: 3.327

8.  LncRNA HOXA-AS2 Activates the Notch Pathway to Promote Cervical Cancer Cell Proliferation and Migration.

Authors:  Qunxiong Wu; Shentao Lu; Li Zhang; Lingjun Zhao
Journal:  Reprod Sci       Date:  2021-06-02       Impact factor: 3.060

9.  Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs.

Authors:  Shaunna L Beedie; Phoebe A Huang; Emily M Harris; Jonathan D Strope; Christopher Mahony; Cindy H Chau; Neil Vargesson; William D Figg
Journal:  FASEB J       Date:  2020-07-17       Impact factor: 5.834

10.  TRIM29 inhibits miR-873-5P biogenesis via CYTOR to upregulate fibronectin 1 and promotes invasion of papillary thyroid cancer cells.

Authors:  Tong Wu; Da-Lin Zhang; Jia-Mei Wang; Jing-Yi Jiang; Xin Du; Xiao-Yan Zeng; Zhen-Xian Du
Journal:  Cell Death Dis       Date:  2020-09-29       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.